Gene · 4610
Papers2,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human Endometrium Derived Induced Pluripotent Stem Cells Are Amenable to Directed Erythroid Differentiation. | Tissue Eng Regen Med | 2023 | 37452918 | PubTator, text mining | PubMed |
| A Cross-Talk about Radioresistance in Lung Cancer-How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies. | Int J Mol Sci | 2023 | 37446385 | PubTator, text mining | PubMed |
| Generation and Functional Characterization of Anti-CD19 Chimeric Antigen Receptor-Natural Killer Cells from Human Induced Pluripotent Stem Cells. | Int J Mol Sci | 2023 | 37445684 | PubTator, text mining | PubMed |
| HOXDeRNA activates a cancerous transcription program and super-enhancers genome-wide. | bioRxiv | 2023 | 37425921 | PubTator, text mining | PubMed |
| Engineering considerations of iPSC-based personalized medicine. | Biomater Res | 2023 | 37420273 | PubTator, text mining | PubMed |
| Growth Transformation of B Cells by Epstein-Barr Virus Requires IMPDH2 Induction and Nucleolar Hypertrophy. | Microbiol Spectr | 2023 | 37409959 | PubTator, text mining | PubMed |
| Three induced pluripotent stem cell lines (TRNDi033-A, TRNDi034-A, TRNDi035-A) generated from lymphoblasts of three apparently healthy individuals. | Stem Cell Res | 2023 | 37393720 | PubTator, text mining | PubMed |
| Generation and characterization of induced pluripotent stem cell line IITGi001-A derived from adult human primary dermal fibroblasts. | Stem Cell Res | 2023 | 37392703 | PubTator, text mining | PubMed |
| Chronic obstructive pulmonary disease alters the genetic landscape and tumor immune microenvironment in lung cancer patients. | Front Oncol | 2023 | 37388220 | PubTator, text mining | PubMed |
| Onco-Pathogen Mediated Cancer Progression and Associated Signaling Pathways in Cancer Development. | Pathogens | 2023 | 37375460 | PubTator, text mining | PubMed |
| An Integrated Computational Analysis of High-Risk SNPs in Angiopoietin-like Proteins (ANGPTL3 and ANGPTL8) Reveals Perturbed Protein Dynamics Associated with Cancer. | Molecules | 2023 | 37375208 | PubTator, text mining | PubMed |
| Advancements in Focal Amplification Detection in Tumor/Liquid Biopsies and Emerging Clinical Applications. | Genes (Basel) | 2023 | 37372484 | PubTator, text mining | PubMed |
| Knockdown of UBQLN1 Functions as a Strategy to Inhibit CRC Progression through the ERK-c-Myc Pathway. | Cancers (Basel) | 2023 | 37370699 | PubTator, text mining | PubMed |
| Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer. | Cancers (Basel) | 2023 | 37370686 | PubTator, text mining | PubMed |
| Review of the Oscillation of Research Regulations for Bioethics in the Republic of Korea: Comparison with Japan. | BioTech (Basel) | 2023 | 37366795 | PubTator, text mining | PubMed |
| HIF and MYC signaling in adrenal neoplasms of the neural crest: implications for pediatrics. | Front Endocrinol (Lausanne) | 2023 | 37361539 | PubTator, text mining | PubMed |
| Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer. | J Hematol Oncol | 2023 | 37355629 | PubTator, text mining | PubMed |
| TCGA Expression Analyses of 10 Carcinoma Types Reveal Clinically Significant Racial Differences. | Cancers (Basel) | 2023 | 37345032 | PubTator, text mining | PubMed |
| BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor-resistant BRCA-mutant ovarian cancer. | Sci Transl Med | 2023 | 37343085 | PubTator, text mining | PubMed |
| Targeted viral adaptation generates a simian-tropic hepatitis B virus that infects marmoset cells. | Nat Commun | 2023 | 37328459 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4610/papers?page=12